Molecular Genetics of a Complement Factor H homolog
Molecular Genetics of a Complement Factor H homolog
批准号:
10275065
负责人:
BRUCE E VOGEL
金额:
$38.63万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-30 至 2026-07-31
关键词:
AdultAffectAfferent NeuronsAgeAge related macular degenerationAlternative Complement PathwayAutopsyBindingBinding SitesBiological AssayBlindnessCaenorhabditis elegansCell physiologyCell surfaceCessation of lifeCiliaCleaved cellComplement Factor HDataDefectDepositionDiseaseDissectionDrusenEnzymesFunctional disorderGenesGeneticGenetic ScreeningGenetic TechniquesGenotypeGoalsHealth Care CostsHeparan Sulfate ProteoglycanHeparitin SulfateHeparitin sulfotransferaseHomeostasisHomologous GeneHumanIndividualInflammationLipidsLocationMembraneMissense MutationModelingMolecularMolecular GeneticsMutationNephronophthisisNeuronsOrganoidsPathogenesisPathogenicityPatientsPhenotypePhotoreceptorsProteoglycanRetinaRisk FactorsRoleStructural defectStructureStructure of retinal pigment epitheliumTestingTimeTissuesUnited StatesUniversitiesVariantWorkbasecomplement pathwaydesignfollow-upgene productgenome wide screeninduced pluripotent stem cellinflammatory milieuinsightloss of function mutationmutantnext generation sequencingnovelscreeningsulfotransferasesyndecan
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Age-related macular degeneration (AMD) is the leading cause of vision loss in the developed
world, affecting 11% of adults over the age of 85. In the United States alone, the disease currently afflicts
10 million individuals, with health care costs in the billions of dollars. The 2005 discovery of a Y402H
variant in complement factor H (CFH) as a risk factor was a major advance in AMD genetics, however
the functional significance of CFH and Y402H and the pathogenic mechanisms that initiate and promote
the disease remain poorly understood. The canonical model of CFH function is that it binds to heparan
sulfate (HS) on cell surfaces where it inhibits alternative complement pathway activity by two distinct
mechanisms. Thus, the prevailing hypothesis for AMD pathogenesis is that missense mutations in HS
binding sites in CFH, that include Y402H, result in defective binding to cell surfaces and ectopic
activation of the alternate complement pathway in the retina. As a consequence of this activation,
increased inflammation, cytolytic activity, and the accumulation of lipid-rich deposits (i.e. drusen)
promote AMD pathogenesis.
In stark contrast to this canonical model, preliminary studies by the PI and co-workers indicate
that CFH-1, a CFH homolog in C. elegans, localizes on the ciliary membrane of C. elegans
mechanosensory neurons in a heparan sulfate dependent manner where it maintains inversin/NPHP-2
within its eponymous cilia compartment. Additional data indicate that the inversin/NPHP-2 compartment
is compromised in human Y402H photoreceptors, suggesting that this novel function for CFH-1 is
conserved in human CFH. On the basis of this data, the PI proposes the radical hypothesis that CFH is
an essential structural component of sensory neuron cilia in the human retina and that structural defects
in photoreceptor cilia promote AMD pathogenesis in patients with CFH loss-of-function mutations. The
aims of this proposal will extend these preliminary studies and use classic molecular and genetic
techniques to dissect the mechanism of CFH-1 localization and function in restricting inversin/NPHP-2
distribution in C. elegans mechansensory neuron cilia. This novel model of CFH-1 function in C. elegans
will be tested in human photoreceptors using a retina organoid model derived from induced pluripotent
stem cells and genotyped post-mortem retina. Together, the proposed work will provide substantial
insight into previously unappreciated CFH functions that are likely to contribute to a unique new model
of AMD pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Genetics of a Complement Factor H homolog
-
批准号:10670958
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2021
-
负责人:BRUCE E VOGEL
-
依托单位:
Molecular Genetics of Hemicentin
-
批准号:6460101
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2002
-
负责人:BRUCE E VOGEL
-
依托单位:
Molecular Genetics of Hemicentin
-
批准号:6727673
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2002
-
负责人:BRUCE E VOGEL
-
依托单位:
Molecular Genetics of Hemicentin
-
批准号:7037474
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2002
-
负责人:BRUCE E VOGEL
-
依托单位:
Molecular Genetics of Hemicentin
-
批准号:6877736
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2002
-
负责人:BRUCE E VOGEL
-
依托单位:
Molecular Genetics of Hemicentin
-
批准号:6622993
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2002
-
负责人:BRUCE E VOGEL
-
依托单位:
CHARACTERIZATION OF THE LAMININ RECEPTOR A CHAIN
-
批准号:3033937
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1991
-
负责人:BRUCE E VOGEL
-
依托单位:
CHARACTERIZATION OF THE LAMININ RECEPTOR A CHAIN
-
批准号:3033936
-
项目类别:
-
资助金额:$2.8万
-
财政年份:1990
-
负责人:BRUCE E VOGEL
-
依托单位:
CHARACTERIZATION OF THE LAMININ RECEPTOR A CHAIN
-
批准号:3033935
-
项目类别:
-
资助金额:$2.1万
-
财政年份:1990
-
负责人:BRUCE E VOGEL
-
依托单位:
海外基金